Selective thrombolysis in a newborn with bilateral renal venous and cerebral thrombosis and heterozygous APC resistance

Nephrology Dialysis Transplantation

Volumn 13, Issue 12, 1998, Pages 3205-3207

  Klinge, Jens ^a   Scharf, Jochem ^a   Rupprecht, Thomas ^a   Böswald, Michael ^a   Hofbeck, Michael ^a  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

APC resistance; Bilateral renal vein thrombosis; Newborn; Selective thrombolysis

Indexed keywords

APC;

ACUTE KIDNEY FAILURE; ARTICLE; BLOOD CLOT LYSIS; CASE REPORT; DRUG RESISTANCE; HUMAN; KIDNEY VEIN THROMBOSIS; MALE; NEWBORN; OCCLUSIVE CEREBROVASCULAR DISEASE; PRIORITY JOURNAL;

EID: 0031758771     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.ndt.a027807     Document Type: Article

References (12)

1. Andrew M, Brooker LA. Hemostatic complications in renal disorders of the young. Pediatr Nephrol 1996; 10: 88-99
2. Haffner D, Wühl E, Zieger B, Grulich-Henn J, Mehls O, Schaefer F. Bilateral renal venous thrombosis in a neonate associated with resistance to activated protein C. Pediatr Nephrol 1996; 10: 737-739
3. Nowak-Göttl U, Schwabe D, Schneider W, Schlösser R, Kreuz W. Thrombolytic therapy with recombinant tissue-type plasminogen activator in renal venous thrombosis in infancy. Lancet 1992; 340: 1105
4. Schwartz GJ, Feld LG, Langford DL. A simple estimated of glomerular filtration rate in full-term infants during the first year of life. J Pediatr 1984; 104 (6): 849-854
5. Klinge J, Hofbeck M, Ries M, Scharf J, Singer H, v.d. Emde J. Thrombolysis of modified Blalock-Taussig shunts in infancy with recombinant plasminogen activator. Z Kardiol 1995; 84 (6): 476-480
6. Jones FE, Black PJ, Cameron JS et al. Local infusion of urokinase and heparin into renal arteries in impending renal cortical necrosis. Br Med J 1975; 4: 547-549
7. Vogelzang RL, Moel DI, Cohn RA, Donaldson JS, Langman CB, Nemcek AA Jr. Acute renal vein thrombosis: successful treatment with intraarterial urokinase. Radiology 1988; 169 (3): 681-682
8. Dahlbäck B, Carlsson M, Svenson PJ. Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C. Proc Natl Acad Sci USA 1993; 90: 1004-1008
9. Bertina RM, Koelman BPC, Koster T et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994; 369: 64-67
10. Griffin JH, Evatt B, Wideman C, Fernàndez JA. Anticoagulant protein C pathway defective in the majority of thrombophilic patients. Blood 1993; 7: 1989-1993
11. Koster T, Rosendaal FR, Ronde de H, Briët, Vandenbroucke JP, Bertina RM. Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study. Lancet 1993; 342: 1503 1506
12. Pohl M, Zimmerhackl LB, Heinen F, Sutor AH, Schneppenheim R, Brandis M. Bilateral renal vein thrombosis and venous sinus thrombosis in a neonate with factor V mutation. J Pediatr 1998; 132 (1): 159-161